As shown in Table 4, the MAF results determined by the two NGS‐based methods, OncomineTM Pan‐Cancer Cell‐Free Assay and GeneReadTM QIAact Lung DNA UMI Cancer Panel, were almost identical (ICC = 0.98; 95% CI: 0.96–0.99 for EGFR‐sensitizing mutations and ICC = 0.97; 95% CI: 0.95–0.98 for T790M). This evidence concerns the gene EGFR and cancer.